KeratoScoop (Rebecca's blog)

30 to 40+ % is pretty staggering when you think about it. It ought to be far more than sufficient to induce glaucoma doctors and general ophthalmologists to sit up and pay more attention to what they're prescribing to their glaucoma and ocular hypertension patients.

Risk factors to develop ocular surface disease 
in treated glaucoma or ocular hypertension patients.

Purpose.
To identify risk factors for developing ocular surface disease (OSD), to verify the prevalence

...

This study talks about glaucoma management yielding better results when the ocular surface is well managed. I am so used to thinking of this the other way around (i.e. glaucoma being treated without reference to dry eye, resulting in damage to the ocular surface) that I kind of gave it a double take as it's suggesting IOP can be decreased by better managing the cornea part of the equation. Still scratching my head a little. The only "duh" in it for me is that patients will be more compliant ...

Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension.

Purpose.
To determine the prevalence of ocular surface diseases and identify risk factors in a population of patients receiving antiglaucomatous eyedrops over the long term.

Methods.
An observational cross-sectional study was designed to investigate ocular surface signs and symptoms using simple clinical tools. An ocular

...